CDIOCARDIO DIAGNOSTICS HOLDINGS, INC.
8-K5.079.01

Oct 15, 2025

Get CDIO alerts

CDIO 8-K — Smart Summary

78% reduction

On October 15, 2025, Cardio Diagnostics Holdings, Inc. held its annual meeting of stockholders. Of 1,763,129 shares eligible to vote as of the August 25, 2025 record date, 927,526 shares (approximately 52.6%) were present or represented by proxy, and stockholders voted on three proposals.

Item 5.07Submission of Matters to a Vote of Security Holders

Director Elections

  • Meeshanthini V. Dogan — 361,246 for / 103,733 withheld (77.7% approval)
  • Warren Hosseinion — 429,765 for / 35,214 withheld (92.4% approval)
  • Wendy J. Betts — 355,919 for / 109,060 withheld (76.5% approval)
  • Paul F. Burton — 428,090 for / 36,889 withheld (92.1% approval)
  • Peter K. Fung — 433,252 for / 31,727 withheld (93.2% approval)
  • James Intrater — 427,266 for / 37,713 withheld (91.9% approval)
  • Robert Philibert — 431,160 for / 33,819 withheld (92.7% approval)

Management Proposals

  • Share Issuance Proposal (approval of future issuance of shares of Common Stock and/or securities convertible into or exercisable for Common Stock equal to 20% or more of Common Stock outstanding in one or more non-public transactions per Nasdaq Marketplace Listing Rule 5635(d)) — 283,304 for / 166,492 against / 15,183 abstain (61.9% approval) — passed
  • Auditor Ratification Proposal (ratification of appointment of Prager Metis CPA's LLC as independent registered public accounting firm for fiscal year ending December 31, 2025) — 813,401 for / 64,820 against / 49,305 abstain (87.2% approval) — passed
§ MORE SUMMARIES

More CDIO Smart Summaries

Other filings for Cardio Diagnostics Holdings, Inc. with a Smart Summary.

8-K$CDIOSmart Summary
8-K Filing
AI-powered cardiac diagnostic tests target $176B U.S. market
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Stock regains Nasdaq compliance after reaching $1.00 minimum bid price
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
1-for-30 reverse stock split effective immediately
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Investor presentation highlights $300B cardiovascular market opportunity
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Nasdaq grants second 180-day extension to regain minimum bid price compliance
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Stockholders approve director slate, reverse split, and auditor ratification
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Stock price falls below $1 minimum bid requirement
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
AI-driven cardiovascular tests target $300B market amid commercial expansion
Read summary of 8-K for CDIO

Never miss a CDIO filing

Get real-time email alerts when CDIO files with the SEC.

See plans
$CDIO 8-K Smart Summary | Portolio